Diana Anderson Among Distinguished Speakers At World Pharma Trials Asia 2010
Dr. Diana Anderson prepares to lead a master class, "Accelerating Patient Recruitment & Retention in Clinical Trials in China" during the 2nd Annual World Pharma Trials in Asia.
- Dallas, TX (1888PressRelease) August 28, 2010 - With a population exceeding 1.3 billion and an expanse of treatment-naïve patients, China is prime territory for conducting clinical research, according to Dr. Diana L. Anderson, president and CEO of global patient recruitment provider D. Anderson & Company. The country's double-digit annual growth rate in R&D surpasses expansion in established markets such as the United States, the United Kingdom and Japan. This phenomenon is fueled by several factors including the establishment of clinical trial laws and the formation of the State Food and Drug Administration. But with progress comes new challenges, namely, increased competition, cost concerns and trial delays.
"It is, therefore, essential to develop targeted recruitment and retention strategies that minimize cost and maximize results," said Dr. Anderson, who 4 years ago led a delegation of clinical research professionals to China in an unprecedented effort to forge relations and exchange ideas for advancing the industry.
Dr. Anderson will draw from nearly two decades of international business experience as she leads attendees of the 2nd Annual World Pharma Trials Asia in a master class titled "Accelerating Patient Recruitment & Retention in Clinical Trials in China" on September 13 at the Gran Melia in Shanghai. World Pharma Trials is the only Asia-focused event in China that convenes regulators and representatives from the world's top pharmaceutical, biotechnology and contract research organizations to share operational best practices.
Targeted to senior-level professionals in the clinical trials sector, Dr. Anderson's master class will equip attendees with the capabilities to: 1) Generate study enthusiasm among investigators and site staff , 2) Compare and contrast centralized versus decentralized recruitment programs and determine which suits study objectives, 3) Choose a budget model that complements program structure, 4) Understand and apply regulations governing patient recruitment practices, 5) Analyze patient demographics and psychographics to tailor recruitment strategies, and 6) Avert attrition by identifying red flags and re-engaging study participants.
About D. Anderson & Company:
With offices in Dallas, Houston and Cincinnati, DAC is a subsidiary of D.L. Anderson International. The company is certified as a Women-Owned Business (WBE) by the Women's Business Enterprise National Council and a continuing education provider through the California Board of Registered Nursing. For more information, visit www.dandersoncompany.com.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam